Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
19
YI Quote, Financials, Valuation and Earnings
Last price:
$3.10
Seasonality move
:
21.11%
Day range:
$2.99 - $3.10
52-week range:
$2.80 - $11.35
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.01x
P/B ratio:
--
Volume:
7.2K
Avg. volume:
12.4K
1-year change:
-59.74%
Market cap:
$25.8M
Revenue:
$2B
EPS (TTM):
-$1.12
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, 111, Inc. has 1914.8% upside to fair value with a price target of -- per share.
YI vs. S&P 500
-
Over the past 5 trading days, 111, Inc. has underperformed the S&P 500 by -14.56% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
111, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
111, Inc. revenues have been falling on a year-over-year basis for 8 quarters in a row. In the most recent quarter 111, Inc. reported revenues of $419.3M.
Earnings Growth
-
111, Inc. earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter 111, Inc. reported earnings per share of -$0.21.
Enterprise value:
103.1M
EV / Invested capital:
1.73x
Price / LTM sales:
0.01x
EV / EBIT:
298.03x
EV / Revenue:
0.05x
PEG ratio (5yr expected):
-0.02x
EV / Free cash flow:
16.92x
Price / Operating cash flow:
4.24x
Enterprise value / EBITDA:
298.03x
Gross Profit (TTM):
$105.5M
Return On Assets:
-3.13%
Net Income Margin (TTM):
-0.62%
Return On Equity:
-26.11%
Return On Invested Capital:
-15.3%
Operating Margin:
-0.07%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $2.1B | $2B | $1.9B | $502.3M | $419.3M | |
| Gross Profit | $126.1M | $116.7M | $105.5M | $29.4M | $24.9M | |
| Operating Income | -$35.2M | -$27.7M | -$2.7M | $246.8K | -$302.8K | |
| EBITDA | -$33M | -$25.6M | -- | $608K | -- | |
| Diluted EPS | -$0.50 | -$0.42 | -$1.12 | -$0.03 | -$0.21 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $431.7M | $393.7M | $437.4M | $411.5M | $335.5M | |
| Total Assets | $484.6M | $430.8M | $460.1M | $431.8M | $348.7M | |
| Current Liabilities | $315.2M | $318.4M | $408.1M | $377.7M | $312.8M | |
| Total Liabilities | $340.4M | $334.6M | $417M | $388M | $318M | |
| Total Equity | $144.1M | $96.2M | $43.2M | $43.8M | $30.7M | |
| Total Debt | $25M | $16.2M | $8.9M | $9.1M | $4.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$25.9M | $15.8M | $6.1M | $15.4M | $5.3M | |
| Cash From Investing | -$4.7M | $8.3M | -$818.2K | $6.9M | -$4.2M | |
| Cash From Financing | $32.3M | -$51.5M | -$10.5M | -$15.5M | $860.7K | |
| Free Cash Flow | -$25.9M | $15.8M | $6.1M | $15.4M | $5.3M | |
YI
Sector
Market Cap
$25.8M
$122.6M
Price % of 52-Week High
26.27%
70.49%
Dividend Yield
0%
0%
Shareholder Yield
33.49%
2.3%
1-Year Price Total Return
-59.74%
-7.14%
Beta (5-Year)
0.484
0.255
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$3.45
200-day SMA
Sell
Level
$6.44
Bollinger Bands (100)
Sell
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$3.62
Relative Strength Index (RSI14)
Sell
Level
33.93
ADX Line
Neutral
Level
0
Williams %R
Buy
Level
-84.3478
50-day SMA
Sell
Level
$3.97
MACD (12, 26)
Buy
Level
0.82
25-day Aroon Oscillator
Sell
Level
-64
On Balance Volume
Neutral
Level
--
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.5116)
Sell
CA Score
(Annual)
Level (-1.8008)
Buy
Beneish M-Score
(Annual)
Level (-3.0978)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (5.1871)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
111, Inc. Is a holding company, which engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.
Stock Forecast FAQ
In the current month, YI has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The YI average analyst price target in the past 3 months is --.
-
Where Will 111, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that 111, Inc. share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About 111, Inc.?
Analysts are divided on their view about 111, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that 111, Inc. is a Sell and believe this share price will drop from its current level to --.
-
What Is 111, Inc.'s Price Target?
The price target for 111, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is YI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for 111, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of YI?
You can purchase shares of 111, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase 111, Inc. shares.
-
What Is The 111, Inc. Share Price Today?
111, Inc. was last trading at $3.10 per share. This represents the most recent stock quote for 111, Inc.. Yesterday, 111, Inc. closed at $2.98 per share.
-
How To Buy 111, Inc. Stock Online?
In order to purchase 111, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get YI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
YI
Sector
P/E ratio
--
16.77x
PEG ratio
-0.02x
0.13x
P/B ratio
--
1.48x
Price / LTM sales
0.01x
0.51x
Growth Metrics
YI
Sector
Revenue growth
-16.54%
2.99%
Earnings growth
-648.56%
5%
Revenue (5-year growth)
28.46%
3.31%
Earnings forecast
--
$0.32
Profitability
YI
Sector
Profitability FY 2024
$115.2M
$260.8M
Return on invested capital
-15.3%
4.37%
Return on assets
-3.13%
3.07%
Return on equity
-26.11%
7.5%
Earnings Date
Last Earnings Date
Dec
17
Next Earnings Date
Mar
19
Estimated Next Earnings Date
Mar
18
Balance Sheet
YI
Sector
Total cash
$78.3M
$87.3M
Short term investments
--
$32.9M
Total assets
$381.9M
$1.1B
Long term debt
$4.9M
$6.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
